| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 69,498 | 75,145 | 79,691 | 84,258 | | Cost of Revenue | 22,543 | 22,711 | 24,624 | 30,011 | | | Gross Profit | 46,955 | 52,434 | 55,067 | 54,247 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 21,248 | 28,211 | 26,438 | 24,433 | | Non Recurring | 15 | 242 |
-
| (35) | | Others | 10,689 | 11,174 | 11,270 | 11,750 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 15,003 | 12,807 | 17,359 | 18,099 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 201 | (14) | 138 | 180 | | Earnings Before Interest And Taxes | 15,204 | 12,793 | 17,497 | 18,279 | | Interest Expense |
-
|
-
|
-
| 11 | | Income Before Tax | 15,204 | 12,793 | 17,497 | 18,268 | | Income Tax Expense | 6,003 | (31,953) | 7,516 | 10,235 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,201 | 44,746 | 9,981 | 8,033 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,201 | 44,746 | 9,981 | 8,033 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $9,201 | $44,746 | $9,981 | $8,033 |
|
1.52% Nasdaq 0.00%
Income Statement
